Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers.
David Wai ChanWai-Yip LamFushun ChenMingo M H YungYau-Sang ChanWai-Sun ChanFangfang HeStephanie S LiuKaren K L ChanBenjamin LiHextan Y S NganPublished in: Clinical epigenetics (2021)
This study demonstrates the significant association of global hypermethylation with poor prognosis and drug resistance in high-grade EOC and highlights the potential of demethylating agents in cancer treatment.